Wencai Q. Ye

State Key Laboratory Of Bioactive Molecules And Druggability Assessment
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

Targeting the polyene chain represents an adjuvant strategy for optimizing polyene antifungals.

Targeting the polyene chain represents an adjuvant strategy for optimizing polyene antifungals.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 21, 2026

Design and Synthesis of Type-A Proanthocyanidin Derivatives as JAK2 Activators to Protect against Chemotherapy-Induced Myelosuppression.

Design and Synthesis of Type-A Proanthocyanidin Derivatives as JAK2 Activators to Protect against Chemotherapy-Induced Myelosuppression.

Journal: Journal of medicinal chemistry

Published: April 06, 2026

Dual-targeting evodiamine analogue overcomes pancreatic cancer immunotherapy resistance by inducing immunogenic cell death.

Dual-targeting evodiamine analogue overcomes pancreatic cancer immunotherapy resistance by inducing immunogenic cell death.

Journal: Biochemical pharmacology

Published: February 22, 2026

Discovery of Chromone Derivatives as Selective BLT1 Inhibitors for Alleviating Acute Lung Injury and Sepsis.

Discovery of Chromone Derivatives as Selective BLT1 Inhibitors for Alleviating Acute Lung Injury and Sepsis.

Journal: Journal of medicinal chemistry

Published: February 16, 2026

Mol-ME: Enhancing Molecular Property Prediction via Multi-Modal Alignment Learning and Ensemble Methods.

Mol-ME: Enhancing Molecular Property Prediction via Multi-Modal Alignment Learning and Ensemble Methods.

Journal: Journal of chemical information and modeling

Published: February 10, 2026

Discovery of unprecedented prenylated indole piperazines and pyrazines through cryptic biosynthetic gene cluster heterologous expression.

Discovery of unprecedented prenylated indole piperazines and pyrazines through cryptic biosynthetic gene cluster heterologous expression.

Journal: Natural products and bioprospecting

Published: January 06, 2026

Monoterpenoid bisindole alkaloids with intestinal anti-inflammatory activity from Kopsia hainanensis.

Monoterpenoid bisindole alkaloids with intestinal anti-inflammatory activity from Kopsia hainanensis.

Journal: Phytochemistry

Published: December 27, 2025

Monoterpenoid bisindole alkaloids with intestinal anti-inflammatory activity from Kopsia hainanensis.

Monoterpenoid bisindole alkaloids with intestinal anti-inflammatory activity from Kopsia hainanensis.

Journal: Phytochemistry

Published: December 27, 2025

Corrigendum to "Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway" [Biochem. Pharmacol. 83(9) (2012) 1251-1260].

Corrigendum to "Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway" [Biochem. Pharmacol. 83(9) (2012) 1251-1260].

Journal: Biochemical pharmacology

Published: December 23, 2025

A dual-target modulator of STK11 and PP2Acα from the flowers of Chrysanthemum indicum mitigates drug-induced liver injury.

A dual-target modulator of STK11 and PP2Acα from the flowers of Chrysanthemum indicum mitigates drug-induced liver injury.

Journal: Journal of advanced research

Published: December 22, 2025

A novel natural compound from Cleistocalyx operculatus enhances the anti-mycobacterial response by inhibiting ferroptosis.

A novel natural compound from Cleistocalyx operculatus enhances the anti-mycobacterial response by inhibiting ferroptosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 10, 2025

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Journal: Journal of virology

Published: December 09, 2025

Showing 1-12 of 118

Last Updated: 09/26/2026